Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Transmembrane protein 56 pseudogene (ENSG00000237249) is a human pseudogene related to the parent gene encoding transmembrane protein 56 (TMEM56)[7]. Pseudogenes such as this do not code for functional proteins due to disabling mutations; they can arise through duplication or retrotransposition events, followed by accumulation of mutations or loss of regulatory elements[1]. Most pseudogenes are considered *non-functional genomic relics*, although in some cases they may yield RNA transcripts with regulatory roles (e.g., competing endogenous RNA activity or miRNA decoy)—this remains speculative and gene-specific[1][8][9]. There is *no evidence* this pseudogene serves as a therapeutic target, nor that it interacts with drugs or is used as a biomarker. GeneCards explicitly lists ENSG00000237249 as a pseudogene and provides no disease or protein function annotation[7]. If searched with the intent to find a pharmacological or protein target, this entry is *incorrect*; pseudogenes are not considered canonical drug targets[1][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Transmembrane protein 56 pseudogene (TMEM56P).